RACGAP1 and ovarian carcinoma: Furthermore, the positions S257, T338, and T580 of RACGAP1 were significantly phosphorylated in tissues of hepatocellular carcinoma, LUAD, and ovarian cancer relative to healthy tissue (Figure 6B–D).